Rare complication of a commonly used antihypertensive agent : A case of hydralazine-induced ANCA-associated vasculitis presenting as rapidly progressive glomerulonephritis

© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd..

Hydralazine-induced ANCA-associated vasculitis is a rare clinical entity, with complications including rapidly progressive glomerulonephritis, pulmonary hemorrhage, and pulmonary-renal syndrome. We present this case to highlight the clinical features that support this challenging diagnosis and to emphasize the importance of prompt recognition and aggressive intervention given its significant morbidity and mortality.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:10

Enthalten in:

Clinical case reports - 10(2022), 2 vom: 01. Feb., Seite e05411

Sprache:

Englisch

Beteiligte Personen:

Warren, Kayle [VerfasserIn]
Vu, Khiem [VerfasserIn]
Shergill, Karandeep [VerfasserIn]
Watson, Brian [VerfasserIn]
Faris, Mohamed [VerfasserIn]

Links:

Volltext

Themen:

Case Reports
Drug‐induced vasculitis
Hydralazine
Pulmonary‐renal syndrome
Pulmonary hemorrhage
Rapidly progressive glomerulonephritis

Anmerkungen:

Date Revised 05.11.2023

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.1002/ccr3.5411

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM336868464